Drug name - Ermeza

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9345772 MYLAN Liquid levothyroxine formulations
Feb, 2035

(12 years from now)

Drugs and Companies using LEVOTHYROXINE SODIUM ingredient

Market Authorisation Date: 29 April, 2022

Treatment: NA

Dosage: SOLUTION;ORAL

More Information on Dosage
Strength Dosage Availability
150MCG/5ML SOLUTION;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.